Onyx Biotec Ltd
Fri 4/09/2026,15:31:57 | NSE : ONYX
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 37.50
Previous Close
₹ 39.25
Volume
126000
Mkt Cap ( ₹ Cr)
₹ 68.00
High
₹ 38.75
Low
₹ 37.30
52 Week High
₹ 51.00
52 Week Low
₹ 24.20
Book Value Per Share
₹ 30.56
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Onyx Biotec Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Onyx Biotec Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Onyx Biotec - Outcome of Board Meeting
-
Onyx Biotec - Corrigendum
-
Onyx Biotec - Updates
-
Onyx Biotec - Public Announcement-Open Offer
-
Onyx Biotec - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
-
Onyx Biotec - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Onyx Biotec - General Updates
-
Onyx Biotec - General Updates
Key fundamentals
Evaluate the intrinsic value of Onyx Biotec Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | |
|---|---|---|---|---|---|
| Assets | 70.5791 | 68.0802 | 55.6591 | 47.4299 | |
| Liabilities | 70.5791 | 68.0802 | 55.6591 | 47.4299 | |
| Equity | 18.1322 | 18.1322 | 13.3222 | 5.9016 | |
| Gross Profit | 3.3971 | 10.3437 | 8.2821 | 4.4579 | |
| Net Profit | -0.2144 | 4.9542 | 3.0316 | 1.8446 | |
| Cash From Operating Activities | -1.4942 | 1.417 | 1.5162 | 1.9526 | |
| NPM(%) | -0.3 | 7.99 | 5.64 | 4.67 | |
| Revenue | 69.4694 | 61.9514 | 53.7488 | 39.4819 | |
| Expenses | 66.0723 | 51.6077 | 45.4667 | 35.024 | |
| ROE(%) | -0.38 | 8.94 | 5.47 | 3.32 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Onyx Biotec Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 860.25 | -1.14 | 21.76 | 0.00 | -26.19 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 109.43 | 0.14 | 1563.29 | 0.00 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 8.32 | -0.48 | 26.00 | 0.00 | 15.42 | 0.00 |
| Astec Lifesciences Ltd | 554.45 | -3.28 | 0.00 | 0.00 | -363.14 | 0.00 |
Company Info
Our Company was incorporated on May 13, 2005 as a private limited company as `Onyx Biotec Private Limited', under the Companies Act, 1956, pursuant to a certificate of incorporation dated May 13, 2005 issued by the Registrar of Companies, Punjab, H.P. & Chandigarh. Further, our Company was converted into a public limited company pursuant to a resolution passed by our Board of Directors in its meeting held on May 1, 2024, and by the Shareholders in an Extraordinary General Meeting held on May 27, 2024 and consequently the name of our Company was changed to `Onyx Biotec Limited' and a fresh certificate of incorporation dated July 23, 2024 was issued by the Registrar of Companies, Central Processing Centre. The corporate identification number of our Company is U24230HP2005PLC028403.Major Events and Milestones:2010-Our Company commenced commercial production at our Unit I with two line of Form Fill and Seal setup with capacity of 2 lacs units per day2017-Capacity expansion at our Unit I from 130 million unit per annum to 230 million units per annum-Our Company received a certificate for Good Manufacturing Practice from Deputy Drugs Controller cum Licensing Authority, Health & Family2023-Our Company commenced commercial production at our Unit II
Our Company was incorporated on May 13, 2005 as a private limited company as `Onyx Biotec Private Limited', under the Companies Act, 1956, pursuant to a certificate of incorporation dated May 13, 2005 issued by the Registrar of Companies, Punjab, H.P. & Chandigarh. Further, our Company was converted into a public limited company pursuant to a resolution passed by our Board of Directors in its meeting held on May 1, 2024, and by the Shareholders in an Extraordinary General Meeting held on May 27, 2024 and consequently the name of our Company was changed to `Onyx Biotec Limited' and a fresh certificate of incorporation dated July 23, 2024 was issued by the Registrar of Companies, Central Processing Centre. The corporate identification number of our Company is U24230HP2005PLC028403.Major Events and Milestones:2010-Our Company commenced commercial production at our Unit I with two line of Form Fill and Seal setup with capacity of 2 lacs units per day2017-Capacity expansion at our Unit I from 130 million unit per annum to 230 million units per annum-Our Company received a certificate for Good Manufacturing Practice from Deputy Drugs Controller cum Licensing Authority, Health & Family2023-Our Company commenced commercial production at our Unit II
Read More
Parent Organisation
Onyx Biotec Ltd.
Founded
13/05/2005
Managing Director
Mr.Sanjay Jain
NSE Symbol
ONYXST
FAQ
The current price of Onyx Biotec Ltd is
The 52-week high for Onyx Biotec Ltd is
The market capitalization of Onyx Biotec Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Onyx Biotec Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Onyx Biotec Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Onyx Biotec Ltd shares.
The CEO of Onyx Biotec Ltd is Mr.Sanjay Jain, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
